AngioDynamics to buy electroporation tumour ablation firm Oncobionic
This article was originally published in Clinica
AngioDynamics has signed a deal to acquire Oncobionic, a firm developing electroporation technology to treat tumours, for up to $25m. The two companies became partners in 2004.
You may also be interested in...
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.
Following closely on the heels of a medical device tax repeal win, AdvaMed CEO Scott Whitaker sat down to discuss how the industry advocacy group ended the Obamacare excise tax and what it has in store for 2020.
“Growth gaps” were the driver for a record-breaking M&A year – but CEOs must remain disciplined when pursuing opportunities, or pay the price down the line.